ClinicalTrials.gov
public full text
Public Domain
Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes Management#1073291
- Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus#407855
- A Study for Patients With Type 2 Diabetes#1102270
- A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics#633853
- A Study Comparing Two Formulations of Insulin Glargine in Healthy Participants#825743
Record · ID 435694
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive